$AKBA
Akebia Therapeutics, Inc. · Small cap ($541M) · $2.04 before its last report
The odds on earnings
Next report estimated around Nov 9, 2026. Based on 9 reports since 2021.
- Typical earnings move is 14%, about 1.9× a typical small cap.
- Moved 10% or more on 56% of its 9 reports (typical for its size: 24%).
Careful: Low-priced stock ($2.04); options and spreads are usually thin.
- Typical move
- 14%
- Moved 10%+
- 56%
- Moved 20%+
- 11%
- Went up
- 33%
- In the opening gap
- 68%
- Streak
- 2 down
- Best day
- +16%
- Worst day
- −20%
A typical small cap moves 7% on earnings on average and hits 10%+ on 24% of reports.
After its 5 biggest moves (10%+ against the Russell 2000), the stock kept going over the next week 40% of the time.
Every report
| Date | Move | At the open | Next 5 days | Next 20 days |
|---|---|---|---|---|
| Nov 10, 2025during day | −18.1% | −15.2% | +10.0% | −8.4% |
| Aug 7, 2025during day | −20.5% | −15.3% | +5.5% | −9.8% |
| May 8, 2025during day | +6.5% | +12.8% | −6.5% | +46.2% |
| Nov 7, 2024during day | −6.8% | −13.0% | +1.6% | +8.8% |
| Mar 2, 2022after close | +14.0% | 0.0% | +21.5% | −67.9% |
| Nov 4, 2021during day | −9.0% | −6.9% | −3.3% | −7.1% |
| Aug 5, 2021during day | +15.7% | −2.8% | −8.9% | +6.3% |
| May 10, 2021during day | −7.1% | −2.2% | +16.8% | +18.1% |
| Feb 25, 2021during day | −18.9% | −11.2% | −1.8% | −5.9% |
Next 5 and 20 days are compared with the Russell 2000 (IWM), starting from the earnings-day close.
History, not predictions. Not investment advice.